The Rise of Chinese Biotech

China is making immense progress in many fields. Biotechnology is no exception.
“A 2024 IQVIA report shows that the share of clinical trials launched by Chinese-headquartered biopharmaceutical companies rose from 3 percent in 2013 to 28 percent in 2023, suggesting a growing involvement of Chinese companies in early-phase drug development.“
More interesting charts on the topic here.